Open Payments

Monument Health Rapid City Hospital

Type
Teaching hospital
Where
Rapid City, SD
Medicare CCN
430077
Received
$661,810 in 115 records, 2023 ($128,008 general, $533,801 research)
Source
CMS Open Payments search ↗

By year

Program yearKindRecordsAmount
2023General payment63$128,008
2023Research payment52$533,801

By company

CompanyRecordsAmountYears
Amgen Inc.4$222,4312023
AstraZeneca UK Limited2$110,1372023
Intuitive Surgical, Inc.13$76,6802023
Eli Lilly and Company8$68,7212023
Esperion Therapeutics, Inc.4$46,0252023
Zimmer Biomet Holdings, Inc.2$25,3122023
American Regent2$20,2632023
Biosense Webster, Inc.6$19,0002023
Boston Scientific Corporation20$16,9872023
Genentech, Inc.2$11,5162023
Boehringer Ingelheim Pharmaceuticals, Inc.3$10,6632023
Linde Gas & Equipment Inc.22$7,2602023
AstraZeneca Pharmaceuticals LP4$5,0002023
AngioDynamics, Inc.1$4,8002023
JAZZ PHARMACEUTICALS INC.4$2,3392023
CSL Behring3$2,1622023
PFIZER INC.2$1,5002023
MicroVention, Inc.1$1,4952023
Tandem Diabetes Care, Inc.1$1,2502023
Insulet Corporation1$1,2502023
Merck Sharp & Dohme LLC1$1,0002023
Alnylam Pharmaceuticals Inc.1$1,0002023
E.R. Squibb & Sons, L.L.C.1$1,0002023
Olympus America Inc.1$1,0002023
Lilly USA, LLC1$1,0002023
Abbott Laboratories1$7502023
Novo Nordisk AS1$6302023
UROGEN PHARMA, INC.2$6032023
SCA Pharmaceuticals, LLC1$312023

By nature of payment

NatureRecordsAmount
Research payment52$533,801
Education14$77,930
Compensation for services other than consulting, including serving as faculty or as a speaker at a v7$20,000
Space rental or facility fees (teaching hospital only)33$18,260
Long term medical supply or device loan2$9,183
Debt forgiveness1$1,000
Grant3$1,000
Gift2$603
Food and Beverage1$31

Records

DateCompanyAmountNatureFormProductStudyYear
2023-12-31AngioDynamics, Inc.$4,800Long term medical supply or device loanIn-kind items and servicesVenaCure 1470 Pro Device, ET2023
2023-12-28Zimmer Biomet Holdings, Inc.$22,248Research paymentCash or cash equivalentPersona Device, KneesPersona Ti-Nidium Personalized Total Knee System2023
2023-12-04Eli Lilly and Company$350Research paymentCash or cash equivalentA RANDOMIZED ACTIVE-CONTROLLED PARALLEL-GROUP PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS2023
2023-11-30MicroVention, Inc.$1,495Research paymentCash or cash equivalentEVALUATION OF THE ROADSAVER STENT USED IN CONJUNCTION WITH THE NANOPARASOL EMBOLIC PROTECTION SYSTEM FOR CAROTID ARTERY 2023
2023-11-13Boston Scientific Corporation$202Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product PIELEGANCE2023
2023-11-11Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-11-09Tandem Diabetes Care, Inc.$1,250Space rental or facility fees (teaching hospital only)Cash or cash equivalentt:slim X2 Insulin Pump with Control-IQ Device, Endocrinology2023
2023-11-07Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-10-31UROGEN PHARMA, INC.$407GiftIn-kind items and servicesJELMYTO Drug, UROTHELIAL CANCER2023
2023-10-26AstraZeneca Pharmaceuticals LP$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2023
2023-10-20AstraZeneca Pharmaceuticals LP$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2023
2023-10-19Merck Sharp & Dohme LLC$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentVERQUVO Drug, CARDIOVASCULAR2023
2023-10-17Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-10-17Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-10-13Boston Scientific Corporation$334GrantIn-kind items and services Device, General - Therapies_EP2023
2023-10-13Boston Scientific Corporation$333GrantIn-kind items and services Device, General - Therapies_EP2023
2023-10-13Boston Scientific Corporation$333GrantIn-kind items and services Device, General - Therapies_EP2023
2023-10-10PFIZER INC.$500Research paymentCash or cash equivalentIBRANCE Drug, ONCOLOGYPALLASPALBOCICLIB COLLABORATIVE ADJUVANT STUDYA RANDOMIZED PHASE III TRIAL OF PALBOCICLIB WITH STANDARD ADJUVANT ENDOCRI2023
2023-10-05PFIZER INC.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentVYNDAQEL Drug, CARDIOVASCULAR2023
2023-10-02Boston Scientific Corporation$1,100Research paymentCash or cash equivalentGeneral Brady Device, General Brady CRMAPPRAISE ATP2023
2023-10-02Boston Scientific Corporation$215Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product PIELEGANCE2023
2023-09-21Boehringer Ingelheim Pharmaceuticals, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2023
2023-09-21AstraZeneca Pharmaceuticals LP$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2023
2023-09-21Boehringer Ingelheim Pharmaceuticals, Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalent2023
2023-08-29Alnylam Pharmaceuticals Inc.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentAMVUTTRA Drug, Genetic Disease2023
2023-08-28Eli Lilly and Company$10,000Research paymentCash or cash equivalentA STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND O2023
2023-08-10Intuitive Surgical, Inc.$8,800EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-08-10Insulet Corporation$1,250EducationCash or cash equivalentOmnipod Device, Insulin Pump2023
2023-08-09Esperion Therapeutics, Inc.$31,687Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2023
2023-08-08Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-08-08Boston Scientific Corporation$61Research paymentCash or cash equivalentGeneral Brady Device, General Brady CRMAPPRAISE ATP2023
2023-08-05Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-07-28Intuitive Surgical, Inc.$30,000EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$8,800EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$8,200EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$8,200EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$5,300EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$3,000EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$1,200EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$900EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$850EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$600EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-28Intuitive Surgical, Inc.$415EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-26Boston Scientific Corporation$1,450Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX PERFORM2023
2023-07-25Boston Scientific Corporation$4,383Long term medical supply or device loanIn-kind items and servicesAVVIGO Guidance System Device, AVVIGO_IC2023
2023-07-25Intuitive Surgical, Inc.$415EducationIn-kind items and servicesDA VINCI SP Device, SURGERY2023
2023-07-17Boston Scientific Corporation$104Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product PIELEGANCE2023
2023-07-10Lilly USA, LLC$1,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-07-07Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-07-06Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-07-03Boston Scientific Corporation$271Research paymentCash or cash equivalentGeneral Brady Device, General Brady CRMAPPRAISE ATP2023
2023-06-28Biosense Webster, Inc.$5,100Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-06-12Boston Scientific Corporation$456Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product PIELEGANCE2023
2023-05-26Novo Nordisk AS$630Research paymentCash or cash equivalentRybelsus Drug, DiabetesNN9924-44372023
2023-05-22SCA Pharmaceuticals, LLC$31Food and BeverageCash or cash equivalent2023
2023-05-19Esperion Therapeutics, Inc.$13,563Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2023
2023-05-15Boston Scientific Corporation$1,000Research paymentCash or cash equivalentGeneral Brady Device, General Brady CRMAPPRAISE ATP2023
2023-05-15Boston Scientific Corporation$969Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX PERFORM2023
2023-05-15Boston Scientific Corporation$632Research paymentCash or cash equivalentGeneral Brady Device, General Brady CRMAPPRAISE ATP2023
2023-05-03Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-05-03Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-05-03Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-05-03Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-05-03UROGEN PHARMA, INC.$196GiftIn-kind items and servicesJELMYTO Drug, UROTHELIAL CANCER2023
2023-04-27AstraZeneca Pharmaceuticals LP$2,000Research paymentCash or cash equivalentFARXIGA Drug, Cardiovascular and MetabolismDapagliflozin in Acute Decompensated Heart Failure2023
2023-04-27Eli Lilly and Company$1,250Research paymentIn-kind items and servicesA STUDY OF DAILY ORAL ORFORGLIPRON (LY3502970) COMPARED WITH INSULIN GLARGINE IN PARTICIPANTS WITH TYPE 2 DIABETES AND O2023
2023-04-13Genentech, Inc.$8,500Research paymentCash or cash equivalentAvastin Biological, BioOncologyA PHASE III MULTICENTER RANDOMIZED PLACEBO CONTROLLED STUDY OF ATEZOLIZUMAB VERSUS PLACEBO IN COM2023
2023-04-12American Regent$1,827Research paymentCash or cash equivalentINJECTAFER Drug, Iron Deficiency AnemiaHeart_FID2023
2023-04-12Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-04-07CSL Behring$1,000Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2023
2023-04-07CSL Behring$1,000Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2023
2023-04-07Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-04-07CSL Behring$162Research paymentCash or cash equivalentA Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy a2023
2023-04-06Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-04-04Eli Lilly and Company$1,380Research paymentIn-kind items and servicesTHE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SU2023
2023-04-04E.R. Squibb & Sons, L.L.C.$1,000Space rental or facility fees (teaching hospital only)Cash or cash equivalentCAMZYOS Drug, Cardiovascular2023
2023-03-24Amgen Inc.$360Research paymentCash or cash equivalentP0 ASCVD Olpasiran Prescreening for CVOT2023
2023-03-23Biosense Webster, Inc.$5,200Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-03-23Biosense Webster, Inc.$2,500Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-03-23Biosense Webster, Inc.$2,500Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-03-23Biosense Webster, Inc.$2,000Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-03-23Biosense Webster, Inc.$1,700Compensation for services other than consulting, including serving as faculty or as a speaker at a vCash or cash equivalent2023
2023-03-21Boehringer Ingelheim Pharmaceuticals, Inc.$8,663Research paymentCash or cash equivalentPhase II dose finding PoCC in DKD2023
2023-03-21JAZZ PHARMACEUTICALS INC.$196Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYEMERGE 402: PHASE IV OBSERVATIONAL STUDY TO COLLECT SAFETY AND OUTCOME DATA IN REAL-WORLD SETTING IN ADULT PATIENTS WITH2023
2023-03-16Zimmer Biomet Holdings, Inc.$3,064Research paymentCash or cash equivalentPersona Device, KneesPersona Ti-Nidium Personalized Total Knee System2023
2023-03-13Boston Scientific Corporation$1,396Research paymentCash or cash equivalentGeneral Brady Device, General Brady CRMAPPRAISE ATP2023
2023-03-06Esperion Therapeutics, Inc.$750Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2023
2023-03-06Esperion Therapeutics, Inc.$25Research paymentCash or cash equivalentNEXLETOL Drug, ANTILIPEMIC AGENTSA RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENC2023
2023-02-28Olympus America Inc.$1,000Debt forgivenessIn-kind items and services2023
2023-02-28Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-02-27Boston Scientific Corporation$3,137Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product CRMLUX DX PERFORM2023
2023-02-27Boston Scientific Corporation$228Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product PIELEGANCE2023
2023-02-23Amgen Inc.$43,681Research paymentCash or cash equivalentPhase 3 - Cardiovascular Outcomes Trial2023
2023-02-17Eli Lilly and Company$30,853Research paymentCash or cash equivalentA RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACE2023
2023-02-14Eli Lilly and Company$2Research paymentIn-kind items and servicesA RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED PHASE 3 STUDY COMPARING THE EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS PLACE2023
2023-02-09JAZZ PHARMACEUTICALS INC.$301Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYEMERGE 402: PHASE IV OBSERVATIONAL STUDY TO COLLECT SAFETY AND OUTCOME DATA IN REAL-WORLD SETTING IN ADULT PATIENTS WITH2023
2023-02-09JAZZ PHARMACEUTICALS INC.$52Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYEMERGE 402: PHASE IV OBSERVATIONAL STUDY TO COLLECT SAFETY AND OUTCOME DATA IN REAL-WORLD SETTING IN ADULT PATIENTS WITH2023
2023-02-08Genentech, Inc.$3,016Research paymentCash or cash equivalentTecentriq Biological, BioOncologyTiragolumab Tecentriq vs Durvalumab in Unresectable Stage III NSCLC2023
2023-02-03Eli Lilly and Company$4,468Research paymentCash or cash equivalentA RANDOMIZED CONTROLLED PRAGMATIC PHASE 3B/4 STUDY OF BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS2023
2023-01-31Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-01-30Eli Lilly and Company$20,417Research paymentCash or cash equivalentTHE EFFECT OF TIRZEPATIDE VERSUS DULAGLUTIDE ON MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES (SU2023
2023-01-25Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-01-24Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-01-21Amgen Inc.$16,909Research paymentCash or cash equivalentRepatha Biological, Cardiology20170625_VESALIUS - CV2023
2023-01-19American Regent$18,436Research paymentCash or cash equivalentINJECTAFER Drug, Iron Deficiency AnemiaHeart_FID2023
2023-01-19AstraZeneca UK Limited$13,944Research paymentCash or cash equivalentA Phase 2b, Randomised, Double-Blind, Placebo-Controlled, Multi Centre Study to Evaluate the Efficacy, Safety and Tolera2023
2023-01-17Boston Scientific Corporation$202Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product PIELEGANCE2023
2023-01-17Boston Scientific Corporation$177Research paymentCash or cash equivalentClinical Trial Product Device, Clinical Trial Product PIELEGANCE2023
2023-01-13Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-01-13Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-01-13Linde Gas & Equipment Inc.$330Space rental or facility fees (teaching hospital only)In-kind items and servicesREQNOXBOX-I Device, Respiratory2023
2023-01-09Amgen Inc.$161,481Research paymentIn-kind items and servicesRepatha Biological, Cardiology20170625_VESALIUS - CV2023
2023-01-09AstraZeneca UK Limited$96,193Research paymentCash or cash equivalentA Phase IIB Randomized Double blinded Placebo controlled Parallel group Study to Evaluate the Efficacy and Safety of MED2023
2023-01-06JAZZ PHARMACEUTICALS INC.$1,788Research paymentCash or cash equivalentZEPZELCA Drug, HEMATOLOGY/ONCOLOGYEMERGE 402: PHASE IV OBSERVATIONAL STUDY TO COLLECT SAFETY AND OUTCOME DATA IN REAL-WORLD SETTING IN ADULT PATIENTS WITH2023
2023-01-05Abbott Laboratories$750Space rental or facility fees (teaching hospital only)Cash or cash equivalentFREESTYLE LIBRE 2 Device, Diabetes Care2023

CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.

The area Census

Pennington CountyRapid City city

County outline, the place (blue), the tract (orange) and the ZIP center (dot).

In Rapid City, SD, county Pennington County, SD, state South Dakota; placed by its city name.

MeasurePlace (city or town)
Rapid City, SD
County
Pennington County, SD
State
South Dakota
Population B0100377,946113,512907,428
Population, 2020 census P174,703109,222886,667
Median age B0100239.140.138.0
Under 18 B0100122.0%22.0%24.2%
65 and over B0100120.7%20.1%18.0%
Households B1100132,36846,370365,544
Foreign born B050022.6%2.5%4.0%
Median household income B19013$70,870$74,517$75,081
Median family income B19113$91,802$92,479$96,562
Per capita income B19301$42,204$42,302$40,550
Poverty rate B1700112.5%11.2%11.9%
Unemployment rate B230252.6%3.2%2.9%
Civilian labor force B2302539,45257,369475,223
Mean commute (minutes) B0801317.519.417.8
Bachelor's degree or higher B1500337.0%34.6%31.9%
Housing units B2500135,57751,681408,584
Owner-occupied B2500362.9%69.3%68.6%
Renters B2500337.1%30.7%31.4%
Median home value B25077$299,400$302,200$257,400
Median gross rent B25064$1,109$1,120$946
White, not Hispanic B0300276.3%77.8%79.8%
Black B030021.2%1.1%2.1%
Hispanic or Latino B030026.1%5.7%4.8%
Asian B030021.3%1.2%1.4%
American Indian and Alaska Native B030027.1%6.0%7.1%

Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Rapid City, SD.

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.